Results 111 to 120 of about 392,114 (322)
Management of xylazine toxicity, overdose, dependence, and withdrawal: A systematic review
Abstract Background and Objectives Xylazine, an alpha‐2‐adrenergic agonist, has been increasingly implicated in substance use and overdose crises. However, little is known about its effects on humans. With the growing public health crisis surrounding xylazine, it has become important to recognize and promptly manage symptoms of xylazine toxicity ...
Philipa Owusu‐Antwi +4 more
wiley +1 more source
Navigating the fine line between focal atrial tachycardia and atrial flutter?
Key Clinical Message Focal atrial tachycardia (FAT) is an organized atrial rhythm >100 beats per minute initiated from a discrete origin and spreading over both atria in a centrifugal pattern. The arrhythmia may be sustained or incessant.
Feisal Rahimpour +5 more
doaj +1 more source
Direct current cardioversion in a case of congenital atrial flutter. [PDF]
R P Barclay, D G Barr
openalex +1 more source
In this large multicenter study, AF before LVAD implantation was not associated with increased risks of mortality, bleeding, stroke, or pump thrombosis, but was linked to a higher incidence of late VAs. ABSTRACT Introduction A substantial proportion of patients receiving left ventricular assist devices (LVADs) present with pre‐existing atrial ...
Miloud Cherbi +9 more
wiley +1 more source
In a pooled analysis, bradycardia was observed in 6% of terlipressin‐treated patients but rarely required a dose interruption or reduction. Arrhythmia serious adverse event incidences were low and similar in both treatment groups. Routine intensive cardiac monitoring for the detection of arrhythmias may not be necessary during terlipressin ...
Jasmohan S. Bajaj +6 more
wiley +1 more source
Abstract Aims The association between glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and depression remains uncertain due to contradictory evidence. We compared the risk of incident depression between GLP‐1 RAs and sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) in overweight or obese adults with type 2 diabetes.
Yu Chang +3 more
wiley +1 more source
Central nervous system involvement in cardiac amyloidosis: Redefining the heart‐brain axis
Central nervous system involvement in cardiac amyloidosis. Amyloidosis is a systemic disease that can directly affect the central nervous system. Furthermore, the amyloid cardiomyopathy can indirectly affect the central nervous system by inducing systemic hypoperfusion and increasing the risk of acute ischaemic stroke.
Domenico Mario Giamundo +3 more
wiley +1 more source
Response of atrial flutter to overdrive atrial pacing and intravenous disopyramide phosphate, singly and in combination. [PDF]
A. John Camm, David Ward, R A Spurrell
openalex +1 more source

